CA
NZ
UK
AU
IND
US
Gary Gerson, Chief Financial Officer of Gladstone Commercial Corp, filed a Form 4 on November 10, 2026, disclosing a purchase of 8,550 shares of common stock on November 9, 2026.
Director Richard Shapiro of Molina Healthcare, Inc. filed a Form 144 notice of proposed sale on November 10, 2026, covering 782 shares of common stock with an aggregate market value of $159,020, to be sold through Piper Sandler on NASDAQ.
Ryan Pardo, an officer of LifeStance Health Group, Inc., filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 587,920 shares of LifeStance common stock with an aggregate market value of $8,466,048, to be executed through Merrill Lynch Pierce Fenner …
CPS Technologies Corp. filed its Form 10-Q for the fiscal quarter ended September 26, 2026, reporting third-quarter and nine-month financial results along with a significant common stock issuance completed during the period.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing a 6% beneficial ownership position in Universal Corp/VA as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 3,010,531 shares of Vanda Pharmaceuticals Inc. common stock as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 14,433,295 shares of common stock in USA Rare Earth Inc as of September 30, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 3,301,893 shares of Vera Therapeutics Inc common stock as of September 30, 2026.
Exagen Inc. filed a Form S-3 registration statement with the SEC on November 10, 2026, covering up to $150.0 million in securities and including a sales agreement prospectus supplement for up to $50.0 million in common stock through TD Securities (USA) LLC.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 4,020,999 shares of Verastem Inc common stock as of September 30, 2026.
Please wait processing your request...